ACIR

ACIR

ACIR‘s mission is to accelerate cancer immunotherapy research by providing a free weekly digest of the most significant advancements in cancer immunobiology, experimental immunotherapy, and innovative methodologies. Their dedicated scientists meticulously review PubMed to curate essential publications for researchers.
Explore their free literature database, delve into our comprehensive CD markers listing, or tune into our latest podcast episodes. Stay informed with ACIR and never miss out on the cutting-edge studies shaping the future of cancer immunotherapy.
ACIR is part of the Fritsch Foundation, a 501c3 organization, EIN 47-3974944.